Jim Cramer just bought Abbott stock: should you too?

A near 2.0% post-earnings decline in Abbott Laboratories (NYSE: ABT) warrants an investment in the health care giant, says Jim Cramer.Cramer’s bullish view on Abbott stockCopy link to sectionHis Charitable Trust bought 275 shares of the medical devices company at $112 each on Monday. Cramer is confident that the weight-loss drugs are not a threat for this Chicago-based maker of FreeStyle Libre (continuous glucose monitoring system).The Mad Money host is bullish on Abbott stock also for the nutrition busines ...